Home/ Tickers/ PFE
PFE PUBLIC EQUITY

PFE Stock Predictions, Graded Against Reality

2 tracked public figures made calls on PFE. Every pick graded against the S&P 500 over matching windows.

Total Calls
2
2 buy · 0 sell
Avg Buy Return
+11.3%
vs S&P +6.8%
Best Buy Call
+12.3%
Yung-Yu Ma · Sep 2025
Figures Tracked
2
public figures with PFE calls

Is PFE a Buy or Sell?

Public buy calls on Pfizer have outperformed the S&P 500. On average, public BUY calls on Pfizer outperformed the S&P 500 by +4.5%.
Worse than indexBeat the index

Pfizer Analyst Ratings, Tracked & Graded

2 calls
Who Signal Date Return S&P Same Window Source
YM
 BUY Sep 28, 2025 +12.3% +7.8% source ↗
MB
 BUY Nov 04, 2025 +10.2% +5.9% source ↗

Who's Predicting Pfizer Stock?

2 figures
Yung-Yu Ma
1 calls on PFE
Avg buy alpha: +4.6%
Michael Burry
1 calls on PFE
Avg buy alpha: +4.3%

Pfizer Stock Prediction Track Records

GotReceipts tracks public buy and sell signals for Pfizer (PFE) and measures outcomes over matched windows. For this ticker model, performance vs the S&P 500 is based on BUY/ADD calls only.

SELL/REDUCE calls are graded directionally and shown as Correct, Incorrect, or Pending. That way, you can quickly see whether following public buy calls added value versus simply holding the index.

Do PFE stock predictions beat the S&P 500?

Yes. Across 2 scored BUY/ADD calls, average return is +11.3% versus +6.8% for the S&P 500, for +4.5% alpha.

Who has the best track record predicting Pfizer?

Yung-Yu Ma currently ranks #1 on PFE, with +12.3% average buy return versus +7.8% for the S&P 500 (+4.6% alpha) across 1 scored buy calls.

Is PFE overvalued or undervalued?

Public prediction track records currently lean bullish on PFE: buy calls have outperformed the index by +4.5% on average.

Should I follow analyst ratings on PFE?

Use analyst and public-figure calls as one input, not a standalone signal. GotReceipts shows historical outcomes versus the S&P 500 so you can judge signal quality before acting.